BridgeMD
Tests treatment safety and results for Achalasia
Official title Safety and Efficacy of a Novel SpydrBlade Flexible Bipolar in POEM
ClinicalTrials.gov ID: NCT07406945
What this study is testing
- What it's testing
- Achalasia is an idiopathic motility disorder, primarily identified by the absence of esophageal peristalsis and the inability of the lower esophageal sphincter (LES) to relax properly. Although it is usually misdiagnosed and treated as gastroesophageal reflux disease (GERD), the main symptom is progressive dysphagia, accompanied by additional symptoms like nocturnal cough, heartburn, weight loss, regurgitation of undigested food and aspiration.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with 18 years of age or older.
- Patients referred to the participating center with a clinical indication for POEM. This includes conditions such as: achalasia, native or failed...
- Patients who provide informed consent.
You likely can't join if
- Patients who have contraindications for EGD.
- Patients with an Eckardt score \< 3 before POEM.
- Positive diagnosis of Chagas disease.
- Patients unable to withstand general anesthesia.
The study team makes the final eligibility decision.
Where it's taking place
- Guayaquil, Ecuador
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guayaquil, Ecuador; Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.